Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

561 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
MSG-15: Super-Bioavailability Itraconazole Versus Conventional Itraconazole in the Treatment of Endemic Mycoses-A Multicenter, Open-Label, Randomized Comparative Trial.
Spec A, Thompson GR, Miceli MH, Hayes J, Proia L, McKinsey D, Arauz AB, Mullane K, Young JA, McGwin G, McMullen R, Plumley T, Moore MK, McDowell LA, Jones C, Pappas PG. Spec A, et al. Among authors: thompson gr. Open Forum Infect Dis. 2024 Jan 29;11(3):ofae010. doi: 10.1093/ofid/ofae010. eCollection 2024 Mar. Open Forum Infect Dis. 2024. PMID: 38440302 Free PMC article.
Real-world Use of Mold-Active Triazole Prophylaxis in the Prevention of Invasive Fungal Diseases: Results From a Subgroup Analysis of a Multicenter National Registry.
Nguyen MH, Ostrosky-Zeichner L, Pappas PG, Walsh TJ, Bubalo J, Alexander BD, Miceli MH, Jiang J, Song Y, Thompson GR 3rd. Nguyen MH, et al. Among authors: thompson gr 3rd. Open Forum Infect Dis. 2023 Aug 7;10(9):ofad424. doi: 10.1093/ofid/ofad424. eCollection 2023 Sep. Open Forum Infect Dis. 2023. PMID: 37674634 Free PMC article.
Efficacy and safety of rezafungin and caspofungin in candidaemia and invasive candidiasis: pooled data from two prospective randomised controlled trials.
Thompson GR 3rd, Soriano A, Honore PM, Bassetti M, Cornely OA, Kollef M, Kullberg BJ, Pullman J, Hites M, Fortún J, Horcajada JP, Kotanidou A, Das AF, Sandison T, Aram JA, Vazquez JA, Pappas PG. Thompson GR 3rd, et al. Lancet Infect Dis. 2024 Mar;24(3):319-328. doi: 10.1016/S1473-3099(23)00551-0. Epub 2023 Nov 23. Lancet Infect Dis. 2024. PMID: 38008099 Free article. Clinical Trial.
Reply to Williams et al.
Nguyen MH, Ostrosky-Zeichner L, Pappas PG, Walsh TJ, Bubalo J, Alexander BD, Miceli MH, Jiang J, Song Y, Thompson GR 3rd. Nguyen MH, et al. Among authors: thompson gr 3rd. Open Forum Infect Dis. 2024 Mar 8;11(3):ofae134. doi: 10.1093/ofid/ofae134. eCollection 2024 Mar. Open Forum Infect Dis. 2024. PMID: 38524232 Free PMC article. No abstract available.
Outcomes by Candida spp. in the ReSTORE Phase 3 trial of rezafungin versus caspofungin for candidemia and/or invasive candidiasis.
Locke JB, Pillar CM, Castanheira M, Carvalhaes CG, Andes D, Aram JA, Andrzejewski C, Bartizal K, Das AF, Sandison T, Thompson GR 3rd, Pappas PG. Locke JB, et al. Among authors: thompson gr 3rd. Antimicrob Agents Chemother. 2024 May 2;68(5):e0158423. doi: 10.1128/aac.01584-23. Epub 2024 Mar 25. Antimicrob Agents Chemother. 2024. PMID: 38526046 Free PMC article. Clinical Trial.
Invasive aspergillosis after pandemic (H1N1) 2009.
Lat A, Bhadelia N, Miko B, Furuya EY, Thompson GR 3rd. Lat A, et al. Among authors: thompson gr 3rd. Emerg Infect Dis. 2010 Jun;16(6):971-3. doi: 10.3201/eid1606.100165. Emerg Infect Dis. 2010. PMID: 20507748 Free PMC article.
Aspergillus Infections. Reply.
Thompson GR III, Young JH. Thompson GR III, et al. N Engl J Med. 2022 Jan 13;386(2):198-199. doi: 10.1056/NEJMc2117819. N Engl J Med. 2022. PMID: 35021001 No abstract available.
561 results